State Street’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10M | Buy |
1,832,920
+408,414
| +29% | +$2.23M | ﹤0.01% | 2603 |
|
|
2025
Q1 | $8.96M | Buy |
1,424,506
+253,824
| +22% | +$1.6M | ﹤0.01% | 2595 |
|
|
2024
Q4 | $4.82M | Buy |
1,170,682
+217,770
| +23% | +$897K | ﹤0.01% | 2999 |
|
|
2024
Q3 | $3.18M | Buy |
952,912
+53,051
| +6% | +$177K | ﹤0.01% | 3157 |
|
|
2024
Q2 | $2.68M | Buy |
899,861
+101,612
| +13% | +$303K | ﹤0.01% | 3198 |
|
|
2024
Q1 | $2.75M | Buy |
798,249
+57,056
| +8% | +$197K | ﹤0.01% | 3171 |
|
|
2023
Q4 | $993K | Buy |
741,193
+32,600
| +5% | +$43.7K | ﹤0.01% | 3482 |
|
|
2023
Q3 | $1.54M | Buy |
708,593
+28,000
| +4% | +$61K | ﹤0.01% | 3422 |
|
|
2023
Q2 | $1.63M | Buy |
680,593
+581,051
| +584% | +$1.39M | ﹤0.01% | 3476 |
|
|
2023
Q1 | $184K | Hold |
99,542
| – | – | ﹤0.01% | 4104 |
|
|
2022
Q4 | $192K | Buy |
99,542
+22,500
| +29% | +$43.4K | ﹤0.01% | 4115 |
|
|
2022
Q3 | $119K | Buy |
77,042
+37,200
| +93% | +$57.5K | ﹤0.01% | 4394 |
|
|
2022
Q2 | $112K | Buy |
39,842
+3,000
| +8% | +$8.43K | ﹤0.01% | 4477 |
|
|
2022
Q1 | $81K | Buy |
+36,842
| New | +$81K | ﹤0.01% | 4700 |
|